comparemela.com
  1. Home
  2. Live Updates
  3. Darren Feldman - Breaking News

Page 2 - Darren Feldman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be.

United statesUnited kingdomSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administration

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be.

United statesUnited kingdomSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administration

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

Complete data from global Phase III ZIRCON study of Telix s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be.

United statesUnited kingdomSan franciscoCharlotte telixKyahn williamsonColin haywardChristian behrenbruchTelix pharmaceuticalsOliver sartor tulane cancer centerAmerican society of clinical oncologyElshad hasanov md anderson cancer centerDrug administrationAndrei iagaru stanford universityAustralian securities exchangePrnewswire telix pharmaceuticals limitedAustralian therapeutic goods administration

Gathering Around Cancer for a decade

The tenth Gathering Around Cancer event brought a network of clinicians and cancer specialists to the Croke Park Conference Centre for this important

New yorkUnited statesUnited kingdomCity ofCroke parkDublin cityTony holohanSeamus oreillyLeo varadkarAlice chenDarren cowzerRisteard olaoideJean benoit burrionFergus keaneDarren feldmanAnne carroll

Monrol Is Partnering With Telix Pharmaceuticals, Supplying Lutetium nca Lu 177 for the Manufacturing

ISTANBUL (BUSINESS WIRE) #MSKCC Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced that the first patient has been dosed in the ‘STARLITE 2’ Phase II study of Telix Pharmaceuticals Limited (Telix) investigational renal cancer therapy product, TLX250 (177Lu-DOTA-girentuximab), at Memorial Sloan Ke.

New yorkUnited statesMemorial sloan kettering cancer centerUnited kingdomAydin kucukDarren feldmanColin haywardMonrol luTelix pharmaceuticalsDrug administrationMonrol nuclear products coAustralian securities exchangeTelix pharmaceuticals limitedAustralian therapeutic goods administrationBristol myers squibbMonrol nuclear products

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.